← SynDRA
TRIOXSALEN
SynDRA canonical compound SYN0007671 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | DNA synthesis inhibitor |
| Indication | eczema | vitiligo |
| Disease area | dermatology |
All known targets
Mechanisms of action (all sources)
Drug classes
- Dermatologic Agents
- Photosensitizing Agents
- Radiation-Sensitizing Agents
- Psoralen
ATC classes
- D05A · ANTIPSORIATICS FOR TOPICAL USE
- D05B · ANTIPSORIATICS FOR SYSTEMIC USE
Cross-references
Synonyms
- trimethylpsoralen
- trioxysalen
- trisoralen
- Trioxysalen
- Trioxysalene
- Trioxisaleno
- 4,5',8-trimethylpsoralen
- Tmp (psoralen)
- NSC-71047
- Trisoralen
- Trimethylpsoralen
- 4,5',8-Trimethylpsoralen
- Elder 8011
- Trioxysalenum
- 2',4,8-Trimethylpsoralen
- 4,5',8-Trimethylpsoralene
- NSC 71047
- 2,5,9-Trimethyl-7H-furo[3,2-g]chromen-7-one
- UNII-Y6UY8OV51T
- Trioxysalene [INN-French]
- Trioxysalenum [INN-Latin]
- NSC71047
- Trioxisaleno [INN-Spanish]
- TRIOXSALIN
- 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-
- EINECS 223-459-0
- 4,8,5'-Trimethylpsoralen
- BRN 0221723
- Y6UY8OV51T
- 2,5,9-trimethylfuro[3,2-g]chromen-7-one
- 2,5,9-Trimethyl-7H-furo(3,2-g)(1)benzopyran-7-one
- 7H-Furo(3,2-g)(1)benzopyran-7-one, 2,5,9-trimethyl-
- 2,5,9-Trimethyl-7H-furo[3,2-g][1]benzopyran-7-one
- DTXCID403716
- CHEBI:28329
- Trioxisalenum
- 2,5,9-trimethylfuro(3,2-g)chromen-7-one
- 4,7,9-trimethyl-2H-furo(3,2-g)chromen-2-one
Look up TRIOXSALEN in the interactive SynDRA portal →